Bernard Gilly, PhD

CEO at GenSight Biologics & Chairman at iBionext

Mr. Bernard Gilly, Ph.D. has over twenty years of experience in the financial & biotech sectors. He co-founded several disruptive technologies start-ups & is currently Chairman of Pixium Vision(2011), EyeTechCare (2012), Gecko Biomedical (2013) & Chronocam (2015). From 2005 to 2009, he founded & was Chairman & Chief Executive Officer of Fovea Pharmaceuticals, a privately owned biotech company, which was acquired by Sanofi in 2009. After the acquisition, he became Senior Vice-President of the Ophthalmology Division of Sanofi until 2012. Prior to Fovea, Dr. Gilly was a partner at Sofinnova Partners from 2000 to 2005.